Because of the disappointing results of clinical trials, minimizing homocysteine levels is no longer the primary goal of our recommendations
Secondary mechanisms growth factor modulation (EGF, FGF) and nitric oxide system interaction have a smaller evidence base and are considered less central to BPC-157's research profile
The LPT Delivery (Lipotabs) use liposomal nanotechnology to improve oral bioavailability and therapeutic uptake across tissues
A2: In cell and animal models, GHK-Cu has been shown to influence collagen and matrix turnover, recruit fibroblasts and endothelial cells, and support revascularization, making it a key tool for investigating skin repair and tissue-regeneration pathways
Histopathological examination showed GHK-Cu reduced mucosal erosion, inflammation (infiltration of immune cells), and goblet cell depletion